EXTRACTABLE & LEACHABLE

  • Home
  • EXTRACTABLE & LEACHABLE
Introduction to Extractable & Leachable (E&L) Testing

Extractable & Leachable (E&L) Testing Services in Navi Mumbai, India

Extractable and Leachable (E&L) testing is a critical component of ensuring the safety, stability, and quality of pharmaceutical products. E&L testing evaluates the potential migration of extractable compounds from packaging materials, bioprocess manufacturing systems, and medical devices into drug formulations. These compounds can leach into the product over time, potentially impacting the stability, efficacy, and safety of the drug.

At Topiox Research in Navi Mumbai, we offer comprehensive E&L testing services to help ensure that your products meet FDA, EMA, and ICH guidelines. Whether your product involves drug packaging, delivery devices, or combination products, our E&L testing solutions are designed to identify and mitigate risks associated with harmful substances that could migrate from packaging into drug formulations.

What Is Extractables and Leachables Testing?

Extractables and leachables (E&L) testing is a pharmaceutical analytical study used to identify, characterize, and evaluate chemical compounds that may migrate from packaging systems, container closure systems, manufacturing components, or medical devices into drug products. E&L testing helps support product safety, regulatory compliance, packaging compatibility, and risk assessment throughout the pharmaceutical product lifecycle.

 

Extractables and Leachables Testing Services in India

Topiox Research Centre provides extractables and leachables testing services for pharmaceutical, biotechnology, and healthcare organizations across India. Our analytical capabilities support packaging compatibility assessments, container closure system evaluations, regulatory submissions, and product safety studies aligned with global pharmaceutical expectations.

What Is Extractables and Leachables?

Extractables: These are substances that are released from materials when they are exposed to solvents or drug formulations under accelerated conditions (e.g., heat, pressure, or solvent exposure). These tests simulate extreme conditions to predict what may leach over time under normal use.

Leachables: These are substances that migrate from packaging materials or components into the drug product under normal storage or use conditions. Leachables are particularly critical because they can directly affect the drug’s quality and patient safety, either through chemical interactions with the drug or direct exposure to the patient.Leachables: These are substances that migrate from packaging materials or components into the drug product under normal storage or use conditions. Leachables are particularly critical because they can directly affect the drug’s quality and patient safety, either through chemical interactions with the drug or direct exposure to the patient.

Both extractables and leachables must be identified and quantified to ensure pharmaceutical products comply with global regulatory standards, especially when drugs come into contact with packaging materials, delivery devices, and other container closures.

Why Extractables and Leachables Testing Matters

Patient Safety

E&L testing is crucial for identifying harmful chemicals that may migrate into drug products. These substances can pose serious health risks to patients if not detected and removed.

Regulatory Compliance

FDA, EMA, and ICH guidelines require E&L testing for pharmaceutical products, particularly those that interact with packaging materials or delivery devices. Meeting these requirements is essential for market approval and regulatory compliance.

Drug Stability

E&L testing ensures that drug formulations maintain their integrity and quality over time, free from harmful interactions with packaging materials or device components.

Formulation Compatibility

Understanding how packaging materials interact with drug formulations is key to optimizing product shelf life and ensuring formulation stability during storage and transport.

Key Components of an Extractables and Leachables Program

AreaPurpose
Extractables StudiesIdentify compounds that may migrate from materials under aggressive conditions
Leachables StudiesDetect compounds that actually migrate into the drug product
Risk AssessmentEvaluate toxicological and product quality impact
Analytical CharacterizationIdentify and quantify unknown compounds
Stability StudiesAssess migration throughout shelf life
Regulatory DocumentationSupport regulatory submissions and compliance activities

 

Analytical Techniques Used for Extractables and Leachables Testing

Extractables and leachables studies often require advanced analytical technologies capable of detecting, identifying, and quantifying compounds at trace levels.

Common analytical techniques include:

  • Gas Chromatography–Mass Spectrometry (GC-MS)
  • Liquid Chromatography–Mass Spectrometry (LC-MS/MS)
  • Inductively Coupled Plasma–Mass Spectrometry (ICP-MS)
  • High-Performance Liquid Chromatography (HPLC)
  • Fourier Transform Infrared Spectroscopy (FTIR)
  • UV-Visible Spectroscopy

The selection of analytical methods depends on the material under investigation, expected compound classes, extraction conditions, and study objectives.

Key E&L Testing Services at Topiox Research

Topiox Research offers a range of extractables and leachables testing services using state-of-the-art methodologies. Our team is equipped with advanced tools and techniques to ensure your pharmaceutical products meet the highest standards of safety and regulatory compliance.

Regulatory Framework for E&L Testing

E&L testing is essential for compliance with several key regulatory guidelines:

  • FDA Guidance for Industry (2013): Leachables and Extractables Testing of Materials Used in Parenteral Drug Products

     

  • ICH Q3D: Elemental Impurities—Guideline for Drug Substances and Drug Products

     

  • ISO 10993: Biological Evaluation of Medical Devices

     

  • USP <661>: Plastic Packaging Systems and Their Materials of Construction

     

  • FDA 21 CFR 820: Quality System Regulations (for medical devices)

     

Compliance with these standards ensures the safety, quality, and regulatory acceptance of pharmaceutical products, facilitating market approval and patient trust.

How Topiox Research Centre Supports Extractables and Leachables Testing

This is your expertise section.

Mention:

  • Risk assessment
  • Study design
  • Method development
  • Compound identification
  • Regulatory support
  • Pharmaceutical packaging studies

Why Choose Topiox Research for E&L Testing?

Advanced Testing Technologies

At Topiox Research, we utilize the latest in Analytical Testing instruments such as HPLC, GC-MS, ICP-MS, and LC-MS to conduct precise and reliable testing for extractables and leachables.

Regulatory Compliance

Our E&L testing services are fully compliant with FDA, EMA, and ICH guidelines, ensuring that all testing and documentation meet the highest standards of regulatory compliance.

Comprehensive Expertise

With years of experience in pharmaceutical testing, our expert team provides detailed E&L testing services for drug packaging, delivery devices, and combination products, ensuring your products are safe and compliant.

Customized Testing Solutions

We offer tailored testing solutions based on the unique characteristics of your product, whether it's oral dosage forms, injectables, or topical formulations.

Efficient Turnaround

Our efficient processes and expert team ensure fast and reliable testing, helping you meet critical timelines and keep your projects moving through the regulatory approval process.

FAQs

Extractables and leachables testing identifies chemical compounds that may migrate from packaging materials, manufacturing components, or medical devices into pharmaceutical products.

 

E&L testing helps evaluate product safety, packaging compatibility, impurity risks, and regulatory compliance.

 

Materials commonly tested include plastic packaging, rubber stoppers, delivery devices (e.g., inhalers, syringes), and combination products that contain both drug substances and delivery systems.

 Testing involves accelerated leaching studies in controlled environments, followed by chromatographic and spectroscopic techniques (HPLC, GC-MS, ICP-MS) to identify and quantify leachable substances.

 Topiox Research provides comprehensive E&L testing services for pharmaceuticals, ensuring regulatory compliance and safety. We offer audit-ready reports to meet FDA, EMA, and ICH requirements.

Common techniques include GC-MS, LC-MS/MS, ICP-MS, HPLC, FTIR, and other advanced analytical methods.

 

E&L studies are commonly performed for injectables, ophthalmics, inhalation products, biologics, topical products, and drug-device combination products.

 

 

Key Takeaway

Extractables and leachables testing helps pharmaceutical manufacturers identify, characterize, and assess compounds that may migrate from packaging systems, medical devices, or manufacturing components into drug products. Through risk assessment, analytical characterization, and regulatory-focused studies, E&L testing supports product safety, quality, and compliance throughout the product lifecycle.

Contact Topiox Research for Extractable & Leachable Testing

Ensure the safety, quality, and regulatory compliance of your pharmaceutical products with Topiox Research. Our comprehensive E&L testing services in Navi Mumbai, India guarantee that your products meet all necessary safety standards for patient health. Contact us to discuss how our expert team can help ensure your pharmaceutical products are safe, compliant, and ready for market approval.